<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872751</url>
  </required_header>
  <id_info>
    <org_study_id>NMRR-21-634-59445</org_study_id>
    <nct_id>NCT04872751</nct_id>
  </id_info>
  <brief_title>Immune Response of Haemodialysis Patients Post Covid-19 Vaccination</brief_title>
  <acronym>Covid-19</acronym>
  <official_title>The Malaysian Study On Hemodialysis Patients SARS-COV-2 Vaccination Immune Response: A Prospective Observational Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penang Hospital, Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penang Hospital, Malaysia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess immune response of end stage renal failure patients&#xD;
      after Covid 19 vaccination&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level</measure>
    <time_frame>up to one year</time_frame>
    <description>Study the antibody synthesis induced by vaccination, among end stage renal failure patients, and the change in its level at 1 month, at 6 months and at 1 year after complete vaccination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level after 1st inoculation of the vaccine (incomplete vaccination)</measure>
    <time_frame>one month</time_frame>
    <description>Study the antibody synthesis and the change in its level after 1st inoculation of the vaccine</description>
  </secondary_outcome>
  <enrollment type="Anticipated">425</enrollment>
  <condition>Immune Response Post Covid 19 Vaccination</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with end-stage renal failure (ESRF) receiving hemodialysis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ESRF patient on hemodialysis who are eligible for the goverment Covid 19 vaccination&#xD;
             programme&#xD;
&#xD;
          -  18 years old and above&#xD;
&#xD;
          -  consented to join the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient who refused to be vaccinated&#xD;
&#xD;
          -  patient who deemed unsuitable for Covid vaccination&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LokeMeng Ong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>XueFang Tan</last_name>
    <phone>6042225333</phone>
    <phone_ext>5576</phone_ext>
    <email>xf821020@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Penang Hospital</name>
      <address>
        <city>George Town</city>
        <state>Penang</state>
        <zip>10990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ong Loke Meng, FRCS</last_name>
      <phone>00 604 2225333</phone>
      <phone_ext>5767</phone_ext>
      <email>onglokemeng@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>May 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penang Hospital, Malaysia</investigator_affiliation>
    <investigator_full_name>Dr.Ong Loke Meng</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

